|
|
Euroscreen Announces European Patent on Human P2Y4 Receptor
EUROSCREEN
|
Euroscreen SA today announced that it was awarded a European patent that covers the use of a G-protein-coupled receptor (GPCR) known as the human P2Y4 receptor. Euroscreen’s patent protects the sequence of P2Y4 receptor and the screening process using ...
Read More
This press release is about: receptor, euroscreen, p2y4, patent, european, g-protein-coupled, significant, pharmaceutical, screening, compounds, human
Published: 2004-06-30
|
|
Euroscreen Awarded US Patent Covering High-Throughput Screening Method Using Aequorin
EUROSCREEN
|
Euroscreen SA, a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a US patent which further protects its useful high-throughput screening platform called AequoScreen™. The claims are related to a widely used diagnostic ...
Read More
This press release is about: euroscreen, screening, high-throughput, patent, calcium-coupled, modulators, aequorin, method, receptors, aequoscreen™, g-protein-coupled
Published: 2005-03-29
|
Euroscreen Enters Collaboration with Cephalon, Inc. to Discover GPCR-Directed Small Molecule
EUROSCREEN
|
Euroscreen s.a. today announced a collaboration with Cephalon, Inc. to discover and develop small molecule therapeutics targeting G-Protein Coupled Receptors, or GPCR, a family of receptors that play a major role in cell signaling. The companies will ...
Read More
This press release is about: euroscreen, cephalon, collaboration, receptors, targets, molecule, companies, aequoscreen™, development, programs, discover
Published: 2004-12-22
|
Euroscreen Extends Its Patent Estate for CCR5 Chemokine Receptor and AIDS
EUROSCREEN
|
First European patent awarded for uses of CCR5 chemokine receptor, a crucial target for novel AIDS therapy - Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key European patent (0 883 687B1) in the ...
Read More
This press release is about: euroscreen, patent, ccr5, receptor, antibodies, infection, companies, portfolio, receptors, g-protein-coupled, significant
Published: 2004-11-04
|
US Patent Issued to ICOS for CCR5 Receptor Antibodies
EUROSCREEN
|
An Important Potential Therapy For AIDS Treatment. Euroscreen SA today announced the issuance of a key US patent to ICOS Corporation (“ICOS”) (Nasdaq: ICOS), on protecting antibodies which specifically bind to the CCR5 chemokine receptor. Euroscreen has ...
Read More
This press release is about: euroscreen, receptor, patent, ccr5, antibodies, infection, icos, membrane, hiv, companies, portfolio
Published: 2004-10-17
|
Euroscreen Receives Key US Patent Covering Screening Methods Using CCR5 Chemokine Receptor
EUROSCREEN
|
CCR5 Chemokine Receptor is a Crucial Target for a Novel AIDS Therapy. Euroscreen s.a., a world leader in G-protein-coupled receptors (GPCRs), today announced the issue of a key US patent in the area of HIV infection. The patent claims screening methods ...
Read More
This press release is about: euroscreen, receptor, patent, ccr5, screening, infection, chemokine, receptors, methods, membrane, hiv
Published: 2004-10-17
|
|
|
|
|
Browse Press Releases: 0-9
A B
C D
E F
G H
I J
K L
M N
O P
Q R
S T
U V
W X
Y Z
|
|
|
« June,2006
|
| S |
M |
T |
W |
T |
F |
S |
|
|
|
|
1 |
2 |
3 |
| 4 |
5 |
6 |
7 |
8 |
9 |
10 |
| 11 |
12 |
13 |
14 |
15 |
16 |
17 |
| 18 |
19 |
20 |
21 |
22 |
23 |
24 |
| 25 |
26 |
27 |
28 |
29 |
30 |
|
|
|